We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

X-Ray Tube Housings Conform to RoHS Regulations

By MedImaging International staff writers
Posted on 16 Jul 2014
CE-marking eligible X-ray Tube Housing assemblies conform to European Union Restriction of Hazardous Substances (RoHS).

Under the RoHS directive the maximum amount of specific materials in electrical and electronic products that pose a threat to the environment and the occupational exposure during manufacturing as well as recycling is regulated. The directive specifically restricts six hazardous substances used in the manufacture of electrical and electronic products. These include Lead (Pb), Mercury (Hg), Cadmium (Cd), Hexavalent Chromium (Cr VI), Polybrominated Biphenyls (PBB), and Polybrominated Diphenyl Ethers (PBDE).

The Dunlee (Aurora, IL, USA) X-ray Tube Housing has been designed, manufactured, and tested and found to be compliant with the legislation laid out in the RoHS Recast Directive 2011/65/EC. The effective RoHS date for product has varied by model, starting in March 2014, but as of May 24, 2014, all CE marked products are RoHS compliant.

Dunlee, a division of Philips healthcare, is a leader in research, design, and manufacture of high-performance replacement tubes for CT, vascular, and general radiography. Dunlee markets and distributes products to OEMs, service providers, and end users worldwide.

Related Links:

Dunlee



Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Illuminator
Trimline Basic
Thyroid Shield
Standard Thyroid Shield
New
Ultrasound Table
Ergonomic Advantage (EA) Line

Latest Radiography News

Novel Breast Imaging System Proves As Effective As Mammography

AI Assistance Improves Breast-Cancer Screening by Reducing False Positives

AI Could Boost Clinical Adoption of Chest DDR